The Latest in Cythemias

Hematology Times

Drug appears feasible for hard-to-treat myelofibrosis

March 20, 2015

Cythemias

Hematology Times

EC approves drug for polycythemia vera

March 18, 2015

Hematology Times

Inhibitor outperforms BAT in myelofibrosis trial

March 10, 2015

Cythemias

Hematology Times

Order of mutations impacts MPN behavior

February 12, 2015

Cythemias

Hematology Times

Ruxolitinib bests standard treatment for PV

January 29, 2015

Cythemias

Hematology Times

CHMP recommends ruxolitinib for PV

January 24, 2015

Hematology Times

Iron overload aids potentially deadly bacteria

January 15, 2015

Cythemias

Hematology Times

CRISPR bests TALEN in iPSCs

January 6, 2015

Hematology Times

Teams map paths to drug resistance in cancers, MPNs

December 30, 2014

Cythemias

Hematology Times

Combo may enhance spleen reductions in MF

December 11, 2014

Cythemias

Hematology Times

Breast cancer drug could treat MPNs, AML

December 5, 2014

Hematology Times

FDA approves first drug for polycythemia vera

December 5, 2014

Hematology Times

DNA finding has implications for MPNs

November 14, 2014

Cythemias

Hematology Times

Hematology drugs on the fast track

November 9, 2014

Hematology Times

FDA lifts clinical hold on imetelstat

November 5, 2014